Answers are grounded in this paper and cite their sources.
BACKGROUND: Pulmonary function decreases immediately after thoracic surgery, a change that is often overlooked and lacks effective intervention strategies. Residual neuromuscular blockade (RNMB) is an important, controllable factor. This study aims to compare the effects of sugammadex versus neostigmine for neuromuscular blockade reversal on pulmonary function recovery at 1 h postoperatively. PATIENTS AND METHODS: from baseline on postoperative days 1 to 3, and pain scores measured by the verbal response scale (VRS) at multiple postoperative time points. Other outcomes include opioid consumption, recovery time of gastrointestinal function, incidence of postoperative nausea and vomiting (PONV), 15-item Quality of Recovery (QoR-15) scores, and the incidence of postoperative pulmonary complications (PPCs). DISCUSSION: This study aims to assess the superiority of sugammadex over neostigmine reversal regimens in improving 1-hour postoperative pulmonary function following thoracoscopic lung resection. The findings will provide mechanistic evidence on whether optimized neuromuscular reversal improves early postoperative pulmonary function, and may inform the design of future confirmatory trials with patient-centered outcomes. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT07309393.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: